178 related articles for article (PubMed ID: 23901906)
1. Therapeutic options for the treatment of postherpetic neuralgia: a systematic review.
Khadem T; Stevens V
J Pain Palliat Care Pharmacother; 2013 Aug; 27(3):268-83. PubMed ID: 23901906
[TBL] [Abstract][Full Text] [Related]
2. Gabapentin for Chronic Neuropathic Pain.
Moore A; Derry S; Wiffen P
JAMA; 2018 Feb; 319(8):818-819. PubMed ID: 29486015
[TBL] [Abstract][Full Text] [Related]
3. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
Gore M; Sadosky A; Tai KS; Stacey B
Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
[TBL] [Abstract][Full Text] [Related]
4. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy.
Ifuku M; Iseki M; Hidaka I; Morita Y; Komatus S; Inada E
Pain Med; 2011 Jul; 12(7):1112-6. PubMed ID: 21692969
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective.
Liedgens H; Hertel N; Gabriel A; Nuijten M; Dakin H; Mitchell S; Nautrup BP
Clin Drug Investig; 2008; 28(9):583-601. PubMed ID: 18666805
[TBL] [Abstract][Full Text] [Related]
6. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review.
Wolff RF; Bala MM; Westwood M; Kessels AG; Kleijnen J
Acta Neurol Scand; 2011 May; 123(5):295-309. PubMed ID: 21039364
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of gabapentin for treatment of postherpetic neuralgia: a meta-analysis of randomized controlled trials.
Meng FY; Zhang LC; Liu Y; Pan LH; Zhu M; Li CL; Li YW; Qian W; Liang R
Minerva Anestesiol; 2014 May; 80(5):556-67. PubMed ID: 24257149
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, efficacy, and tolerability of a once-daily gastroretentive dosage form of gabapentin for the treatment of postherpetic neuralgia.
Chen C; Han CH; Sweeney M; Cowles VE
J Pharm Sci; 2013 Apr; 102(4):1155-64. PubMed ID: 23381946
[TBL] [Abstract][Full Text] [Related]
9. Treatment of postherpetic neuralgia: focus on pregabalin.
Cappuzzo KA
Clin Interv Aging; 2009; 4():17-23. PubMed ID: 19503762
[TBL] [Abstract][Full Text] [Related]
10. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology.
Dubinsky RM; Kabbani H; El-Chami Z; Boutwell C; Ali H;
Neurology; 2004 Sep; 63(6):959-65. PubMed ID: 15452284
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
Tarride JE; Gordon A; Vera-Llonch M; Dukes E; Rousseau C
Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
[TBL] [Abstract][Full Text] [Related]
12. Review of current guidelines on the care of postherpetic neuralgia.
Argoff CE
Postgrad Med; 2011 Sep; 123(5):134-42. PubMed ID: 21904096
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over.
Gupta A; Li S
Drugs Aging; 2013 Dec; 30(12):999-1008. PubMed ID: 24163280
[TBL] [Abstract][Full Text] [Related]
15. A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia.
O'Connor AB; Noyes K; Holloway RG
J Am Geriatr Soc; 2007 Aug; 55(8):1176-84. PubMed ID: 17661955
[TBL] [Abstract][Full Text] [Related]
16. Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern?
Goodman CW; Brett AS
N Engl J Med; 2017 Aug; 377(5):411-414. PubMed ID: 28767350
[No Abstract] [Full Text] [Related]
17. Real-world treatment of post-herpetic neuralgia with gabapentin or pregabalin.
Johnson P; Becker L; Halpern R; Sweeney M
Clin Drug Investig; 2013 Jan; 33(1):35-44. PubMed ID: 23179473
[TBL] [Abstract][Full Text] [Related]
18. Gabapentin-induced neurologic toxicities.
Bookwalter T; Gitlin M
Pharmacotherapy; 2005 Dec; 25(12):1817-9. PubMed ID: 16305301
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial.
Rullán M; Bulilete O; Leiva A; Soler A; Roca A; González-Bals MJ; Lorente P; Llobera J;
Trials; 2017 Jan; 18(1):24. PubMed ID: 28088231
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of gabapentin 1800 mg treatment for post-herpetic neuralgia: a meta-analysis of randomized controlled trials.
Fan H; Yu W; Zhang Q; Cao H; Li J; Wang J; Shao Y; Hu X
J Clin Pharm Ther; 2014 Aug; 39(4):334-42. PubMed ID: 24806220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
